Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

Autor: Dias CS; Medical Sciences, Amgen, One Amgen Center Drive, Thousand Oaks, California 91320-1799, USA. claptond@amgen.com, Shaywitz AJ, Wasserman SM, Smith BP, Gao B, Stolman DS, Crispino CP, Smirnakis KV, Emery MG, Colbert A, Gibbs JP, Retter MW, Cooke BP, Uy ST, Matson M, Stein EA

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2012 Nov 06; Vol. 60 (19), pp. 1888-98. Date of Electronic Publication: 2012 Oct 17.